Phlebopress, capsules 300 mg 60 pcs

Semisynthetic bioflavonoid (rutin derivative) of benzopyran class, has P-vitamin activity, has venotonic, angioprotective, anti-inflammatory and anti-edema effect, reduces capillary permeability and fragility. Its pharmacodynamic properties are associated with the participation of troxerutin bioflavonoids in redox processes and hyaluronidase inhibition. Inhibiting hyaluronidase, troxerutin stabilizes hyaluronic acid of cell membranes and reduces their permeability.
It has antioxidant activity, as a result of which it prevents oxidation of ascorbic acid, adrenaline and lipids. In addition, it reduces capillary permeability and fragility, prevents damage to the basal membrane of endothelial cells when it is exposed to various factors. Troxerutin increases the density of the vascular wall, reduces the exudation of the liquid part of the plasma and diapedesis of blood cells.
Reduces exudative inflammation in the vascular wall, reducing platelet adhesion to its surface.
Inhibits aggregation and increases the degree of red blood cell deformation. Application of troxerutin is possible both in the initial and in the late stages of treatment of chronic venous insufficiency, it is possible to use as one of the components of complex treatment. Troxerutin reduces swelling and heaviness in the legs, reduces the intensity of pain and cramps, improves tissue trophism. Troxerutin relieves symptoms associated with hemorrhoids (pain, exudation, itching, bleeding). Due to influence on capillary permeability and resistance walls troxerutin helps to slow down progression of diabetic retinopathy.
The effect of troxerutin on the rheological properties of the blood prevents the development of retinal vascular microthrombosis.

Indications

The drug Phlebopress® capsules 300 mg is used as part of complex therapy for the following diseases:
• chronic venous insufficiency;
• trophic disorders in chronic venous insufficiency and trophic ulcers;
• varicose veins;
• superficial thrombophlebitis, periphlebitis;
• postthrombotic syndrome;
• post-traumatic swelling and soft tissue hematomas;
• as an auxiliary treatment after sclerotherapy and/or removal of varicose veins of the lower extremities;
• hemorrhoids (to relieve symptoms);
• diabetic angiopathy, retinopathy.

Pharmacological effect

A semi-synthetic bioflavonoid (rutin derivative) of the benzopyran class, has P-vitamin activity, has venotonic, angioprotective, anti-inflammatory and decongestant effects, reduces capillary permeability and fragility. Its pharmacodynamic properties are associated with the participation of the bioflavonoids troxerutin in redox processes and inhibition of hyaluronidase. By inhibiting hyaluronidase, troxerutin stabilizes hyaluronic acid in cell membranes and reduces their permeability.
It has antioxidant activity, which prevents the oxidation of ascorbic acid, adrenaline and lipids. In addition, it reduces the permeability and fragility of capillaries, prevents damage to the basement membrane of endothelial cells when exposed to various factors. Troxerutin increases the density of the vascular wall, reduces the exudation of the liquid part of the plasma and the diapedesis of blood cells.
Reduces exudative inflammation in the vascular wall, reducing platelet adhesion to its surface.
Inhibits aggregation and increases the degree of deformation of red blood cells. The use of troxerutin is possible both in the initial and late stages of treatment of chronic venous insufficiency; it can be used as one of the components of complex treatment. Troxerutin reduces swelling and a feeling of heaviness in the legs, reduces the intensity of pain and cramps, and improves tissue trophism. Troxerutin relieves symptoms associated with hemorrhoids (pain, exudation, itching, bleeding). Due to its effect on the permeability and resistance of capillary walls, troxerutin helps slow the progression of diabetic retinopathy.
The effect of troxerutin on the rheological properties of blood helps prevent the development of retinal vascular microthrombosis.

Active ingredient

Troxerutin

Composition

Composition per 1 capsule: active substance: troxerutin – 300.00 mg

Contraindications

• Hypersensitivity to troxerutin and other components of the drug;
• Peptic ulcer of the stomach, duodenum, chronic gastritis in the acute phase;
• Lactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome;
• Pregnancy (I trimester);
• Breastfeeding period;
• Children under 18 years of age (limited experience of use)

Manufacturer

Ozon, Russia